All news from Anaesthesiology

Association Between Suicide Rates And Hypoxia

Following an extensive analysis of published studies, researchers have found that while suicide rates are higher at higher altitudes, they are unlikely caused by hypoxia, (low oxygen) at these elevations.

The study was published this month in the journal High Altitude Medicine & Biology, says suicide victims at high altitudes differ significantly from those at lower elevations in demographics, mental health, and suicide-related characteristics.

Rotten Food Detection Improved Using Wireless Tagging Device

When it comes to the "smell test," the nose isn't always the best judge of food quality. Now in a study appearing in ACS' journal Nano Letters, scientists report that they have developed a wireless tagging device that can send signals to smartphones warning consumers and food distributors when meat and other perishables have spoiled. They say this new sensor could improve the detection of rotten food so it is tossed before consumers eat it.

Heart Rhythm Disorders Can Be Reduced By Wearable Defibrillators

A new study examined that Wearable cardioverter defibrillators vest-like devices that deliver electric shocks to interrupt a dangerous heart rhythm may be a safe and effective alternative to surgically implanted devices in children with ventricular heart rhythm disorders that put them at risk for sudden cardiac death. The study was published in Circulation: Arrhythmia and Electrophysiology, an American Heart Association journal.

Gonorrhea: Gender-Specific Signatures Identified

The World Health Organization estimates that 78 million people worldwide are infected with gonorrhea each year. Men with infections tend to have obvious symptoms while women are often asymptomatic or experience mild symptoms. In both men and women, the infection usually clears with antibiotic treatment.

Hepatitis Delta Virus: Genetically Humanized Mice Provide Potential Treatment Options

Hepatitis delta virus (HDV) causes the most aggressive form of viral hepatitis in humans, putting at least 20 million people worldwide at risk of developing liver fibrosis, cirrhosis, and liver cancer.

Efforts to develop effective treatments against HDV have been hampered by the fact that laboratory mice are not susceptible to the virus. But, in a study published in the journal Science Translational Medicine, researchers describe a genetically humanized mouse that can be persistently infected with HDV.